Terms: = Brain cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Treatment
566 results:
1. Strategies to Improve Drug Delivery Across the Blood-brain Barrier for Glioblastoma.
Narsinh KH; Perez E; Haddad AF; Young JS; Savastano L; Villanueva-Meyer JE; Winkler E; de Groot J
Curr Neurol Neurosci Rep; 2024 May; 24(5):123-139. PubMed ID: 38578405
[TBL] [Abstract] [Full Text] [Related]
2. Special populations in metastatic renal cell carcinoma.
Goodstein T; Goldberg I; Acikgoz Y; Hasanov E; Srinivasan R; Singer EA
Curr Opin Oncol; 2024 May; 36(3):186-194. PubMed ID: 38573208
[TBL] [Abstract] [Full Text] [Related]
3. Current outstanding challenges in germ cell tumors.
Salous T; Adra N
Curr Opin Oncol; 2024 May; 36(3):169-173. PubMed ID: 38573206
[TBL] [Abstract] [Full Text] [Related]
4. Clinical diagnosis and management of multiple cerebral ring-enhancing lesions-study of 50 patients at a tertiary healthcare center.
Patel A; More B; Rege I; Ranade D
J Cancer Res Ther; 2024 Jan; 20(1):112-117. PubMed ID: 38554307
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic factors and real-life applicability of prognostic models for patients with bone metastases of carcinoma.
Dalkir KA; Mirioglu A; Kundakci B; Bagir M; Deveci MA; Ozberlas HS
Acta Orthop Traumatol Turc; 2024 Jan; 58(1):62-67. PubMed ID: 38525512
[TBL] [Abstract] [Full Text] [Related]
6. Integrated Molecular and Histological Insights for Targeted Therapies in Mesenchymal Sinonasal Tract Tumors.
Hoch CC; Knoedler L; Knoedler S; Bashiri Dezfouli A; Schmidl B; Trill A; Douglas JE; Adappa ND; Stögbauer F; Wollenberg B
Curr Oncol Rep; 2024 Mar; 26(3):272-291. PubMed ID: 38376625
[TBL] [Abstract] [Full Text] [Related]
7. Blood-brain Barrier Disruption for the treatment of Primary brain Tumors: Advances in the Past Half-Decade.
Virtanen PS; Ortiz KJ; Patel A; Blocher WA; Richardson AM
Curr Oncol Rep; 2024 Mar; 26(3):236-249. PubMed ID: 38329660
[TBL] [Abstract] [Full Text] [Related]
8. PARP Inhibitors in Breast cancer: a Short Communication.
Daly GR; AlRawashdeh MM; McGrath J; Dowling GP; Cox L; Naidoo S; Vareslija D; Hill ADK; Young L
Curr Oncol Rep; 2024 Feb; 26(2):103-113. PubMed ID: 38236558
[TBL] [Abstract] [Full Text] [Related]
9. Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas.
Youssef G; Wen PY
Curr Neurol Neurosci Rep; 2024 Feb; 24(2):17-25. PubMed ID: 38170429
[TBL] [Abstract] [Full Text] [Related]
10. Simultaneous Comparisons of 25 Acute Migraine Medications Based on 10 Million Users' Self-Reported Records From a Smartphone Application.
Chiang CC; Fang X; Horvath Z; Cadiou F; Urani A; Poh W; Narimatsu H; Cheng Y; Dodick DW
Neurology; 2023 Dec; 101(24):e2560-e2570. PubMed ID: 38030397
[TBL] [Abstract] [Full Text] [Related]
11. Shifting Strategies in the treatment of Pediatric Craniopharyngioma.
Gabay S; Merchant TE; Boop FA; Roth J; Constantini S
Curr Oncol Rep; 2023 Dec; 25(12):1497-1513. PubMed ID: 38015373
[TBL] [Abstract] [Full Text] [Related]
12. Systemic treatment for brain Metastasis and Leptomeningeal Disease in Breast cancer Patients.
Puri S; Chaudhry A; Bayable A; Ganesh A; Daher A; Gadi VK; Maraka S
Curr Oncol Rep; 2023 Dec; 25(12):1419-1430. PubMed ID: 37924439
[TBL] [Abstract] [Full Text] [Related]
13. Advances in treatment of Diffuse Midline Gliomas.
Cacciotti C; Wright KD
Curr Neurol Neurosci Rep; 2023 Dec; 23(12):849-856. PubMed ID: 37921944
[TBL] [Abstract] [Full Text] [Related]
14. The Spectrum of Headache in Leptomeningeal Metastases: A Comprehensive Review with Clinical Management Guidelines.
Wilcox JA; Estrera R; Boire A
Curr Pain Headache Rep; 2023 Nov; 27(11):695-706. PubMed ID: 37874457
[TBL] [Abstract] [Full Text] [Related]
15. Combination of radiosurgery and immunotherapy in brain metastases: balance between efficacy and toxicities.
Botticella A; Dhermain F
Curr Opin Neurol; 2023 Dec; 36(6):587-591. PubMed ID: 37865858
[TBL] [Abstract] [Full Text] [Related]
16. Novel approaches to treatment of leptomeningeal metastases.
Primdahl D; Cohen-Nowak A; Kumthekar P
Curr Opin Neurol; 2023 Dec; 36(6):592-602. PubMed ID: 37865856
[TBL] [Abstract] [Full Text] [Related]
17. Epilepsy in gliomas: recent insights into risk factors and molecular pathways.
Rudà R; Bruno F; Pellerino A
Curr Opin Neurol; 2023 Dec; 36(6):557-563. PubMed ID: 37865836
[TBL] [Abstract] [Full Text] [Related]
18. Schwannomatosis: a Realm Reborn: year one.
Planet M; Kalamarides M; Peyre M
Curr Opin Oncol; 2023 Nov; 35(6):550-557. PubMed ID: 37820090
[TBL] [Abstract] [Full Text] [Related]
19. Preclinical glioma models in neuro-oncology: enhancing translational research.
Barachini S; Morelli M; Santonocito OS; Mazzanti CM
Curr Opin Oncol; 2023 Nov; 35(6):536-542. PubMed ID: 37820088
[TBL] [Abstract] [Full Text] [Related]
20. Molecular Profiling and Targeted Therapies in Gliomas.
Felistia Y; Wen PY
Curr Neurol Neurosci Rep; 2023 Oct; 23(10):627-636. PubMed ID: 37812369
[TBL] [Abstract] [Full Text] [Related]
[Next]
